Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2021

Upgrades

For Royal Dutch Shell PLC RDS, Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, Royal Dutch Shell had an EPS of $0.42, compared to year-ago quarter EPS of $0.37. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Royal Dutch Shell closed at $40.56 at the end of the last trading period.

JP Morgan upgraded the previous rating for Duck Creek Technologies Inc DCT from Neutral to Overweight. Duck Creek Technologies earned $0.03 in the third quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Duck Creek Technologies shows a 52-week-high of $59.40 and a 52-week-low of $33.91. Moreover, at the end of the last trading period, the closing price was at $40.72.

Gordon Haskett upgraded the previous rating for Airbnb Inc ABNB from Underperform to Buy. Airbnb earned $1.14 in the first quarter. The current stock performance of Airbnb shows a 52-week-high of $219.94 and a 52-week-low of $121.50. Moreover, at the end of the last trading period, the closing price was at $146.69.

For Boeing Co BA, Wolfe Research upgraded the previous rating of Underperform to Peer Perform. For the first quarter, Boeing had an EPS of $1.53, compared to year-ago quarter EPS of $1.70. The stock has a 52-week-high of $278.57 and a 52-week-low of $141.58. At the end of the last trading period, Boeing closed at $238.29.

Morgan Stanley upgraded the previous rating for Republic Services Inc RSG from Equal-Weight to Overweight. Republic Services earned $0.93 in the first quarter, compared to $0.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $114.10 and a 52-week-low of $80.29. Republic Services closed at $112.65 at the end of the last trading period.

Raymond James upgraded the previous rating for Old Dominion Freight Line Inc ODFL from Market Perform to Outperform. For the first quarter, Old Dominion Freight Line had an EPS of $1.70, compared to year-ago quarter EPS of $1.11. The current stock performance of Old Dominion Freight Line shows a 52-week-high of $276.09 and a 52-week-low of $171.57. Moreover, at the end of the last trading period, the closing price was at $257.62.

For Electronic Arts Inc EA, BMO Capital upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Electronic Arts had an EPS of $1.23, compared to year-ago quarter EPS of $1.08. At the moment, the stock has a 52-week-high of $150.30 and a 52-week-low of $110.15. Electronic Arts closed at $141.39 at the end of the last trading period.

For Southwestern Energy Co SWN, Mizuho upgraded the previous rating of Neutral to Buy. In the first quarter, Southwestern Energy showed an EPS of $0.29, compared to $0.10 from the year-ago quarter. The current stock performance of Southwestern Energy shows a 52-week-high of $5.85 and a 52-week-low of $2.18. Moreover, at the end of the last trading period, the closing price was at $5.35.

According to Wells Fargo, the prior rating for Hanesbrands Inc HBI was changed from Equal-Weight to Overweight. In the first quarter, Hanesbrands showed an EPS of $0.39, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.82 and a 52-week-low of $10.85. Hanesbrands closed at $18.12 at the end of the last trading period.

According to Needham, the prior rating for Radware Ltd RDWR was changed from Hold to Buy. In the first quarter, Radware showed an EPS of $0.17, compared to $0.14 from the year-ago quarter. The current stock performance of Radware shows a 52-week-high of $32.59 and a 52-week-low of $21.66. Moreover, at the end of the last trading period, the closing price was at $31.04.

According to Stifel, the prior rating for Poshmark Inc POSH was changed from Hold to Buy. In the first quarter, Poshmark earned $0.33. The stock has a 52-week-high of $104.98 and a 52-week-low of $33.23. At the end of the last trading period, Poshmark closed at $41.96.

For Terex Corp TEX, JP Morgan upgraded the previous rating of Neutral to Overweight. In the first quarter, Terex showed an EPS of $0.60, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $55.60 and a 52-week-low of $17.52. At the end of the last trading period, Terex closed at $47.54.

According to JP Morgan, the prior rating for PACCAR Inc PCAR was changed from Neutral to Overweight. PACCAR earned $1.35 in the first quarter, compared to $1.03 in the year-ago quarter. The current stock performance of PACCAR shows a 52-week-high of $103.19 and a 52-week-low of $74.29. Moreover, at the end of the last trading period, the closing price was at $88.31.

For AGCO Corp AGCO, JP Morgan upgraded the previous rating of Neutral to Overweight. For the first quarter, AGCO had an EPS of $2.00, compared to year-ago quarter EPS of $0.86. The stock has a 52-week-high of $158.62 and a 52-week-low of $53.12. At the end of the last trading period, AGCO closed at $131.36.

See all analyst ratings upgrades.

Downgrades

According to LightShed Partners, the prior rating for Crown Castle International Corp CCI was changed from Buy to Neutral. In the first quarter, Crown Castle Intl showed an EPS of $1.71, compared to $1.42 from the year-ago quarter. The current stock performance of Crown Castle Intl shows a 52-week-high of $203.39 and a 52-week-low of $146.15. Moreover, at the end of the last trading period, the closing price was at $203.08.

According to LightShed Partners, the prior rating for American Tower Corp AMT was changed from Buy to Neutral. American Tower earned $2.46 in the first quarter, compared to $2.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $280.65 and a 52-week-low of $197.50. American Tower closed at $279.99 at the end of the last trading period.

According to JP Morgan, the prior rating for Sapiens International Corp NV SPNS was changed from Overweight to Neutral. In the first quarter, Sapiens Intl Corp showed an EPS of $0.27, compared to $0.20 from the year-ago quarter. The current stock performance of Sapiens Intl Corp shows a 52-week-high of $35.85 and a 52-week-low of $25.66. Moreover, at the end of the last trading period, the closing price was at $26.15.

According to Maxim Group, the prior rating for VirTra Inc VTSI was changed from Buy to Hold. VirTra earned $0.08 in the first quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $10.17 and a 52-week-low of $3.13. At the end of the last trading period, VirTra closed at $8.21.

For Taiwan Liposome Co Ltd TLC, HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. For the first quarter, Taiwan Liposome Co had an EPS of $0.08, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $12.65 and a 52-week-low of $4.07. Taiwan Liposome Co closed at $6.80 at the end of the last trading period.

According to Societe Generale, the prior rating for EDP Renovaveis SA EDRVF was changed from Buy to Hold. The stock has a 52-week-high of $25.83 and a 52-week-low of $15.88. At the end of the last trading period, EDP Renovaveis closed at $25.10.

B of A Securities downgraded the previous rating for Edison International EIX from Buy to Neutral. For the first quarter, Edison had an EPS of $0.79, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $66.68 and a 52-week-low of $48.47. At the end of the last trading period, Edison closed at $58.20.

According to Goldman Sachs, the prior rating for Alstom SA ALSMY was changed from Buy to Neutral. The stock has a 52-week-high of $6.70 and a 52-week-low of $4.27. At the end of the last trading period, Alstom closed at $4.39.

Citigroup downgraded the previous rating for First Solar Inc FSLR from Buy to Neutral. In the first quarter, First Solar showed an EPS of $0.81, compared to $0.85 from the year-ago quarter. The current stock performance of First Solar shows a 52-week-high of $112.50 and a 52-week-low of $55.35. Moreover, at the end of the last trading period, the closing price was at $94.29.

See all analyst ratings downgrades.

Initiations

Industrial Alliance initiated coverage on NervGen Pharma Corp NGENF with a Speculative Buy rating. The price target for NervGen Pharma is set to $6.00. At the moment, the stock has a 52-week-high of $2.43 and a 52-week-low of $0.90. NervGen Pharma closed at $1.31 at the end of the last trading period.

For ATAI Life Sciences NV ATAI, Cowen & Co. initiated coverage, by setting the current rating at Outperform. The stock has a 52-week-high of $22.91 and a 52-week-low of $16.50. At the end of the last trading period, ATAI Life Sciences closed at $19.00.

Citigroup initiated coverage on ATAI Life Sciences NV ATAI with a Buy rating. The price target for ATAI Life Sciences is set to $26.00. The current stock performance of ATAI Life Sciences shows a 52-week-high of $22.91 and a 52-week-low of $16.50. Moreover, at the end of the last trading period, the closing price was at $19.00.

With a Buy rating, Citigroup initiated coverage on Compass Pathways PLC CMPS. The price target seems to have been set at $67.00 for Compass Pathways. In the first quarter, Compass Pathways earned $0.35. At the moment, the stock has a 52-week-high of $61.69 and a 52-week-low of $22.51. Compass Pathways closed at $37.25 at the end of the last trading period.

With an Overweight rating, Atlantic Equities initiated coverage on Squarespace Inc SQSP. The price target seems to have been set at $70.00 for Squarespace. The stock has a 52-week-high of $64.71 and a 52-week-low of $42.82. At the end of the last trading period, Squarespace closed at $55.21.

Berenberg initiated coverage on ATAI Life Sciences NV ATAI with a Buy rating. The price target for ATAI Life Sciences is set to $35.00. The stock has a 52-week-high of $22.91 and a 52-week-low of $16.50. At the end of the last trading period, ATAI Life Sciences closed at $19.00.

With a Positive rating, Susquehanna initiated coverage on Sun Country Airlines Holdings Inc SNCY. The price target seems to have been set at $42.00 for Sun Country Airlines. In the first quarter, Sun Country Airlines earned $0.09. The stock has a 52-week-high of $44.13 and a 52-week-low of $31.02. At the end of the last trading period, Sun Country Airlines closed at $34.74.

With a Positive rating, Susquehanna initiated coverage on Allegiant Travel Co ALGT. The price target seems to have been set at $245.00 for Allegiant Travel. Allegiant Travel earned $3.58 in the first quarter, compared to $2.05 in the year-ago quarter. The stock has a 52-week-high of $271.29 and a 52-week-low of $101.44. At the end of the last trading period, Allegiant Travel closed at $193.24.

With a Positive rating, Susquehanna initiated coverage on Frontier Group Holdings Inc ULCC. The price target seems to have been set at $20.00 for Frontier Group Holdings. In the first quarter, Frontier Group Holdings showed an EPS of $0.86, compared to $0.12 from the year-ago quarter. The stock has a 52-week-high of $22.70 and a 52-week-low of $14.80. At the end of the last trading period, Frontier Group Holdings closed at $15.61.

With a Buy rating, Ladenburg Thalmann initiated coverage on Ayala Pharmaceuticals Inc AYLA. The price target seems to have been set at $29.00 for Ayala Pharmaceuticals. For the first quarter, Ayala Pharmaceuticals had an EPS of $0.74, compared to year-ago quarter EPS of $1.32. At the moment, the stock has a 52-week-high of $28.68 and a 52-week-low of $7.74. Ayala Pharmaceuticals closed at $10.60 at the end of the last trading period.

With an Overweight rating, Cantor Fitzgerald initiated coverage on ATAI Life Sciences NV ATAI. The price target seems to have been set at $45.00 for ATAI Life Sciences. The stock has a 52-week-high of $22.91 and a 52-week-low of $16.50. At the end of the last trading period, ATAI Life Sciences closed at $19.00.

For Insperity Inc NSP, William Blair initiated coverage, by setting the current rating at Outperform. In the first quarter, Insperity showed an EPS of $1.82, compared to $1.70 from the year-ago quarter. At the moment, the stock has a 52-week-high of $95.78 and a 52-week-low of $61.06. Insperity closed at $93.40 at the end of the last trading period.

William Blair initiated coverage on Kinnate Biopharma Inc KNTE with an Outperform rating. For the first quarter, Kinnate Biopharma had an EPS of $0.40, compared to year-ago quarter EPS of $1.07. The current stock performance of Kinnate Biopharma shows a 52-week-high of $48.75 and a 52-week-low of $21.27. Moreover, at the end of the last trading period, the closing price was at $22.61.

With a Buy rating, Argus Research initiated coverage on Cloudflare Inc NET. The price target seems to have been set at $125.00 for Cloudflare. Cloudflare earned $0.03 in the first quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Cloudflare shows a 52-week-high of $111.97 and a 52-week-low of $32.70. Moreover, at the end of the last trading period, the closing price was at $107.28.

Loop Capital initiated coverage on Marquee Raine Acquisition Corp MRAC with a Hold rating. The price target for Marquee Raine Acquisition is set to $11.00. The current stock performance of Marquee Raine Acquisition shows a 52-week-high of $13.11 and a 52-week-low of $9.71. Moreover, at the end of the last trading period, the closing price was at $9.89.

With a Buy rating, Stifel initiated coverage on Tremor International Ltd TRMR. The price target seems to have been set at $26.00 for Tremor Intl. The stock has a 52-week-high of $22.68 and a 52-week-low of $16.16. At the end of the last trading period, Tremor Intl closed at $22.49.

With an Outperform rating, Wedbush initiated coverage on Cyteir Therapeutics Inc CYT. The price target seems to have been set at $40.00 for Cyteir Therapeutics. For the third quarter, Cyteir Therapeutics had an EPS of $0.90, compared to year-ago quarter EPS of $0.74. The current stock performance of Cyteir Therapeutics shows a 52-week-high of $23.10 and a 52-week-low of $16.00. Moreover, at the end of the last trading period, the closing price was at $19.65.

With a Buy rating, Chardan Capital initiated coverage on Femasys Inc FEMY. The price target seems to have been set at $25.00 for Femasys. The stock has a 52-week-high of $13.75 and a 52-week-low of $7.00. At the end of the last trading period, Femasys closed at $7.41.

With an Overweight rating, Morgan Stanley initiated coverage on Cyteir Therapeutics Inc CYT. The price target seems to have been set at $33.00 for Cyteir Therapeutics. Cyteir Therapeutics earned $0.90 in the third quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $23.10 and a 52-week-low of $16.00. At the end of the last trading period, Cyteir Therapeutics closed at $19.65.

With an Outperform rating, Credit Suisse initiated coverage on ATAI Life Sciences NV ATAI. The price target seems to have been set at $25.00 for ATAI Life Sciences. The current stock performance of ATAI Life Sciences shows a 52-week-high of $22.91 and a 52-week-low of $16.50. Moreover, at the end of the last trading period, the closing price was at $19.00.

Raymond James initiated coverage on Tremor International Ltd TRMR with an Outperform rating. The price target for Tremor Intl is set to $27.00. The stock has a 52-week-high of $22.68 and a 52-week-low of $16.16. At the end of the last trading period, Tremor Intl closed at $22.49.

RBC Capital initiated coverage on ATAI Life Sciences NV ATAI with a Sector Perform rating. The price target for ATAI Life Sciences is set to $19.00. The stock has a 52-week-high of $22.91 and a 52-week-low of $16.50. At the end of the last trading period, ATAI Life Sciences closed at $19.00.

RBC Capital initiated coverage on Calamos Global Dynamic Income Fund CHW with a Sector Perform rating. The price target for Calamos Global Dynamic is set to $14.00. The current stock performance of Calamos Global Dynamic shows a 52-week-high of $11.17 and a 52-week-low of $7.33. Moreover, at the end of the last trading period, the closing price was at $11.11.

JMP Securities initiated coverage on Tremor International Ltd TRMR with a Market Outperform rating. The price target for Tremor Intl is set to $30.00. At the moment, the stock has a 52-week-high of $22.68 and a 52-week-low of $16.16. Tremor Intl closed at $22.49 at the end of the last trading period.

With a Market Outperform rating, JMP Securities initiated coverage on Phreesia Inc PHR. The price target seems to have been set at $80.00 for Phreesia. Phreesia earned $0.11 in the first quarter, compared to $0.16 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.59 and a 52-week-low of $26.50. Phreesia closed at $67.61 at the end of the last trading period.

With a Sell rating, Benchmark initiated coverage on Roblox Corp RBLX. The price target seems to have been set at $75.00 for Roblox. For the first quarter, Roblox had an EPS of $0.46, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $103.87 and a 52-week-low of $60.50. At the end of the last trading period, Roblox closed at $86.54.

Needham initiated coverage on Tremor International Ltd TRMR with a Buy rating. The price target for Tremor Intl is set to $28.00. At the moment, the stock has a 52-week-high of $22.68 and a 52-week-low of $16.16. Tremor Intl closed at $22.49 at the end of the last trading period.

SVB Leerink initiated coverage on Century Therapeutics Inc IPSC with an Outperform rating. The price target for Century Therapeutics is set to $33.00. The stock has a 52-week-high of $30.03 and a 52-week-low of $18.93. At the end of the last trading period, Century Therapeutics closed at $27.25.

With a Buy rating, Jefferies initiated coverage on Codex DNA Inc DNAY. The price target seems to have been set at $23.00 for Codex DNA. At the moment, the stock has a 52-week-high of $25.70 and a 52-week-low of $16.50. Codex DNA closed at $16.57 at the end of the last trading period.

With a Buy rating, Jefferies initiated coverage on Nautilus Biotechnology Inc NAUT. The price target seems to have been set at $13.00 for Nautilus Biotechnology. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Nautilus Biotechnology closed at $10.00 at the end of the last trading period.

Cowen & Co. initiated coverage on Codex DNA Inc DNAY with an Outperform rating. At the moment, the stock has a 52-week-high of $25.70 and a 52-week-low of $16.50. Codex DNA closed at $16.57 at the end of the last trading period.

Goldman Sachs initiated coverage on Ambrx Biopharma Inc AMAM with a Buy rating. The price target for Ambrx Biopharma is set to $53.00. The stock has a 52-week-high of $22.87 and a 52-week-low of $14.94. At the end of the last trading period, Ambrx Biopharma closed at $21.30.

With a Buy rating, B of A Securities initiated coverage on Cyteir Therapeutics Inc CYT. The price target seems to have been set at $23.00 for Cyteir Therapeutics. For the third quarter, Cyteir Therapeutics had an EPS of $0.90, compared to year-ago quarter EPS of $0.74. The current stock performance of Cyteir Therapeutics shows a 52-week-high of $23.10 and a 52-week-low of $16.00. Moreover, at the end of the last trading period, the closing price was at $19.65.

With a Buy rating, B of A Securities initiated coverage on Ambrx Biopharma Inc AMAM. The price target seems to have been set at $26.00 for Ambrx Biopharma. The current stock performance of Ambrx Biopharma shows a 52-week-high of $22.87 and a 52-week-low of $14.94. Moreover, at the end of the last trading period, the closing price was at $21.30.

For ATAI Life Sciences NV ATAI, Canaccord Genuity initiated coverage, by setting the current rating at Buy. The stock has a 52-week-high of $22.91 and a 52-week-low of $16.50. At the end of the last trading period, ATAI Life Sciences closed at $19.00.

Cowen & Co. initiated coverage on Ambrx Biopharma Inc AMAM with an Outperform rating. The current stock performance of Ambrx Biopharma shows a 52-week-high of $22.87 and a 52-week-low of $14.94. Moreover, at the end of the last trading period, the closing price was at $21.30.

With a Buy rating, HC Wainwright & Co. initiated coverage on Tempest Therapeutics Inc TPST. The price target seems to have been set at $51.00 for Tempest Therapeutics. The current stock performance of Tempest Therapeutics shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $24.19.

For Taiwan Semiconductor Manufacturing Co Ltd TSM, Needham initiated coverage, by setting the current rating at Buy. In the first quarter, Taiwan Semiconductor showed an EPS of $0.96, compared to $0.75 from the year-ago quarter. At the moment, the stock has a 52-week-high of $142.19 and a 52-week-low of $63.19. Taiwan Semiconductor closed at $122.63 at the end of the last trading period.

For zooplus AG ZLPSF, Credit Suisse initiated coverage, by setting the current rating at Outperform. At the moment, the stock has a 52-week-high of $322.54 and a 52-week-low of $158.45. zooplus closed at $322.00 at the end of the last trading period.

JP Morgan initiated coverage on Century Therapeutics Inc IPSC with an Overweight rating. The price target for Century Therapeutics is set to $40.00. The current stock performance of Century Therapeutics shows a 52-week-high of $30.03 and a 52-week-low of $18.93. Moreover, at the end of the last trading period, the closing price was at $27.25.

With an Overweight rating, JP Morgan initiated coverage on Cyteir Therapeutics Inc CYT. The price target seems to have been set at $30.00 for Cyteir Therapeutics. For the third quarter, Cyteir Therapeutics had an EPS of $0.90, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $23.10 and a 52-week-low of $16.00. At the end of the last trading period, Cyteir Therapeutics closed at $19.65.

DA Davidson initiated coverage on Decarbonization Plus Acquisition Corp DCRB with a Buy rating. The price target for Decarbonization Plus is set to $21.00. The stock has a 52-week-high of $19.95 and a 52-week-low of $9.87. At the end of the last trading period, Decarbonization Plus closed at $10.00.

Goldman Sachs initiated coverage on Okta Inc OKTA with a Buy rating. The price target for Okta is set to $312.00. Okta earned $0.10 in the first quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Okta shows a 52-week-high of $294.00 and a 52-week-low of $185.05. Moreover, at the end of the last trading period, the closing price was at $245.55.

With an Overweight rating, Piper Sandler initiated coverage on Century Therapeutics Inc IPSC. The price target seems to have been set at $38.00 for Century Therapeutics. The stock has a 52-week-high of $30.03 and a 52-week-low of $18.93. At the end of the last trading period, Century Therapeutics closed at $27.25.

With an Overweight rating, Keybanc initiated coverage on Codex DNA Inc DNAY. The price target seems to have been set at $30.00 for Codex DNA. At the moment, the stock has a 52-week-high of $25.70 and a 52-week-low of $16.50. Codex DNA closed at $16.57 at the end of the last trading period.

With an Outperform rating, Cowen & Co. initiated coverage on Molecular Partners AG MOLN. The price target seems to have been set at $50.00 for Molecular Partners. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Molecular Partners closed at $19.25 at the end of the last trading period.

See all analyst ratings initiations.

Posted In: BZI-RatingsUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.